Development and validation of a dynamic nomogram for predicting brain metastasis in stage III NSCLC patients undergoing definitive chemoradiotherapy | BMC Cancer
This study developed and validated a dynamic nomogram model that integrates clinicopathological features (e.g., sex, histology, EGFR status,…